Abstract

We report two cases illustrating a potential use of transdermal scopolamine to reduce salivation in acute stroke. We speculate that this may lead to reduced aspiration and possibly also less pneumonia. However, the treatment is associated with side effects. Finally, we suggest that this use of transdermal scopolamine in stroke may be a topic for a randomized clinical trial.

ACESSE O PERIÓDICO